MSR1 and neoplasm: However, the immunogenicity seen with the inhibition of Msr1 on tumor derived DCs is not through the induction of IL-1β, as we show that irradiated tumor derived DCs produce significantly more IL-1β than non-irradiated tumor derived DCs incubated with either no, 10,25 or 50 ug/ml of Msr1.